Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Change in Cash: 2009-2025

Historic Change in Cash for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to -$17.2 million.

  • BIO-TECHNE's Change in Cash fell 148.18% to -$17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.6 million, marking a year-over-year decrease of 209.52%. This contributed to the annual value of $10.4 million for FY2025, which is 136.12% up from last year.
  • As of Q3 2025, BIO-TECHNE's Change in Cash stood at -$17.2 million, which was down 180.05% from $21.5 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Change in Cash ranged from a high of $53.3 million in Q2 2023 and a low of -$51.0 million during Q1 2022.
  • Moreover, its 3-year median value for Change in Cash was -$10.0 million (2024), whereas its average is -$1.8 million.
  • Per our database at Business Quant, BIO-TECHNE's Change in Cash spiked by 500.31% in 2021 and then crashed by 3,122.78% in 2023.
  • BIO-TECHNE's Change in Cash (Quarterly) stood at $15.5 million in 2021, then slumped by 103.70% to -$575,000 in 2022, then tumbled by 3,122.78% to -$18.5 million in 2023, then skyrocketed by 46.08% to -$10.0 million in 2024, then crashed by 148.18% to -$17.2 million in 2025.
  • Its Change in Cash stands at -$17.2 million for Q3 2025, versus $21.5 million for Q2 2025 and -$36.9 million for Q1 2025.